Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Deferred Taxes (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Deferred Taxes data on record, last reported at $3.8 million in Q4 2025.

  • For Q4 2025, Deferred Taxes rose 149.59% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $13.8 million, up 175.74%, while the annual FY2025 figure was -$4.9 million, 59.48% up from the prior year.
  • Deferred Taxes reached $3.8 million in Q4 2025 per PAHC's latest filing, up from $2.2 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $8.4 million in Q2 2025 and bottomed at -$7.7 million in Q4 2024.
  • Average Deferred Taxes over 5 years is -$826900.0, with a median of -$403000.0 recorded in 2021.
  • Peak YoY movement for Deferred Taxes: crashed 20600.0% in 2023, then skyrocketed 259.7% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$506000.0 in 2021, then skyrocketed by 78.66% to -$108000.0 in 2022, then plummeted by 3432.41% to -$3.8 million in 2023, then tumbled by 102.88% to -$7.7 million in 2024, then skyrocketed by 149.59% to $3.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were $3.8 million in Q4 2025, $2.2 million in Q3 2025, and $8.4 million in Q2 2025.